Cardiovascular Disease, Diabetes Mellitus Type 2
2 clinical trials · Condition
◉ Watch Cardiovascular Disease, Diabetes Mellitus Type 2
| Record | Firm | Date |
|---|---|---|
| A Study on The Potential of Aleglitazar to Reduce Cardiovascular Risk in Patients With Stable Cardiovascular Disease and Glucose Abnormalities (NCT01715818) | Hoffmann-La Roche | 2012-12-01 |
Track Cardiovascular Disease, Diabetes Mellitus Type 2 automatically
Every clearance here is in the API, with alerts when new ones post.